By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Financire de Tubize – 2025 half-year financial report
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Health > Financire de Tubize – 2025 half-year financial report
Financire de Tubize – 2025 half-year financial report
Health

Financire de Tubize – 2025 half-year financial report

GlobeNews Wire
Last updated: 03/08/2025 12:38 AM
GlobeNews Wire
Published: 03/08/2025
Share
SHARE

August 02, 2025 02:00 ET  | Source: Financière de Tubize SA

Half-year financial report 2025
Regulated information 2 August 2025

The board of directors of Financière de Tubize has established the 2025 half-year report. This report is available on the website www.financiere-tubize.be.

  • Profit for the first half of 2025: € 95.6 million (€ 92.9 million in 2024, + 2.8%),
  • Dividend received from UCB: € 98.1 million (€ 1.39 per share, an increase of 2.2% compared to the previous year),
  • 2024 Dividend paid to Financière de Tubize’s shareholders in 2025 of € 46.3 million (€ 1.04 per share, an increase of 7.22% compared to the previous year),
  • Acquisition, in 2025, of 24,487 UCB shares, for a total amount of € 4.37 million, at an average price of € 178.3. Our stake in UCB has increased from 36.27% on 31 December 2024 to 36,28% on 30 June 2025,
  • Decrease of outstanding bank borrowings from € 41.3 million at 31 December 2024 to € nil at 30 June 2025.
CGTNXinjiang in its most prosperous period ever: white paper
Plume Appoints Former NASA Engineer, Startup CTO Mik Cox as Senior Vice President of Technology Innovation
ArkBio’s New Drug Application for ADHD Therapeutic Azstarys Accepted and Granted Priority Review by China NMPA
DAR GLOBAL AWARDS ENABLING WORKS CONTRACT FOR TRUMP INTERNATIONAL HOTEL & TOWER, DUBAI TO EDRAFOR EMIRATES LLC
Kymera Therapeutics Announces Pricing of $250 Million Public Offering
TAGGED:2025Adventurefinancialfinancirehalf-yearnewsreporttubize
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics
News

Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics

11/12/2025
Mesoblast Announces Changes to Board of Directors’ Leadership Roles
Emerald Clinical Trials Confirms CEO Transition and Continuity Plan
Aramco and Pasqal make history with Saudi Arabia’s first quantum computer
Factor2 Energy Raises US$9.1M to Unlock Scalable Geothermal Power from Geologically Stored CO
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?